In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments
Pedro Nazareth Aguiar(Sociedade Brasileira de Oncologia Clínica), Gilberto Lopes(University of Miami), Jacob J. Adashek(South Texas Accelerated Research Therapeutics), Felipe Roitberg(World Health Organization), Auro del Giglio(Faculdade de Medicina do ABC), Carmélia Maria Noia Barreto(Instituto de Medicina Avançada)
Cited by 22
Related Papers
Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications
|Photodiagnosis and Photodynamic Therapy|2005|910
The biology of cancer-related fatigue: a review of the literature
|Supportive Care in Cancer|2015|305
Cancer-related fatigue: a practical review
|Annals of Oncology|2011|220
Burnout in cancer professionals: a systematic review and meta-analysis
|European Journal of Cancer Care|2008|200